Study Details

General Information

Forest NEB-MD-20

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study To Evaluate The Effect of 5 MG or 20 MG Nebivolol Once Daily on Blood Pressure in Patients With Systolic Stage 2 Hypertension

ProtocolNEB-MD-20
IdentifierNEB-MD-20
UIDc3fd029d-7942-4aae-be03-bc6faef11ef6
StatusDone - Archived
Phase3
CategoryHypertension
Launch Year2010
NCT Number-
Created2010-05-21 16:00
Last Updated2010-05-21 16:00

Description

No description provided.

Comment

No comment.

Target Dates

NameDateRequired
Enrollment ClosedNo
Enrollment OpenNo
First Patient First VisitNo
Site Initiation Mtg.2010-01-01No
PI Meeting StartNo
PI Meeting EndNo
PI Meeting ArrivalNo
PI Meeting DepartureNo
Closeout Date2010-11-03No
Final PatientVisitNo
PreStudy Selection VisitNo
Target Date 12No
Target Date 13No
Target Date 14No

Leadership

RoleStaffLoginRequired
PrincipalUnger, JeffreyJUngerNo
Recruiter-No
CoordinatorCalleros, JessicaJNCallerosNo
RegulatoryAguirre, SandraSAguirreNo

Custom Fields

No custom fields.

Sponsor & Organization

SponsorForest Research Institute
DivisionForest Research Institute
TeamForest Research Institute
Managing SiteCatalina Research Institute, LLC
Organization

Contacts

IRB Ref
CRO
CRO Ref
Correspondence0

Opportunity

Probability0
Comment
Status ColorGainsboro
Currency-
Mayra Sibley

2 Hours

Hi there, I'm Jesse and you?
You

3 minutes

My name is Anne Clarc.
Mayra Sibley

40 seconds

Nice to meet you Anne.
How can i help you?